The prognostic significance of osteopontin in head and neck cancer has been reported in patients treated by definite radiotherapy [15, 16, 18, 39] and is thought to relate to an association with tumor hypoxia and malignant phenotype. Here, SPP1 is linked to head and neck cancer.